Wells Fargo & Company Panbela Therapeutics, Inc. Transaction History

Wells Fargo & Company

  • $407 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$0.07 - $6528.0 $5 - $476,544
73 Added 57.03%
201 $0
Q3 2022

Nov 14, 2022
BUY
$0.24 - $8712.0 $12 - $435,600
50 Added 64.1%
128 $0
Q2 2022

Aug 12, 2022
BUY
$0.61 - $2.1 $47 - $163
78 New
78 $0

Others Institutions Holding PBLA

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Panbela Therapeutics, Inc.

PBLA Quotes by TradingView
  • Ticker PBLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,774,000
  • Market Cap $7.69M
  • Description
  • Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer...
More about PBLA
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email